A Randomised Double Blind Placebo Controlled Clinical Trial of Centchroman (Saheli) in breast pain and nodularity (Benign Breast Disorders).

Trial Profile

A Randomised Double Blind Placebo Controlled Clinical Trial of Centchroman (Saheli) in breast pain and nodularity (Benign Breast Disorders).

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Centchroman (Primary)
  • Indications Breast disorders; Breast pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Sep 2010 Actual initiation date changed from 10 Oct 2007 to 20 Dec 2008 as reported by ClinicalTrials.gov.
    • 05 Aug 2010 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
    • 02 Jul 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top